| Literature DB >> 22253999 |
Karen Plawecki1, Karen Chapman-Novakofski.
Abstract
Bone health is an important issue in aging. Calcium and vitamin D currently have the most focus in published research on nutrition and bone health in aging, although evidence from published research is not conclusive. A systematic review was conducted to determine the impact of dietary and supplemental interventions focused on calcium and vitamin D over the past 10 years. Using key words to search, and search limits (aging population, English), 62 papers were found related to diet, nutrition, and bone; and 157 were found related to calcium and bone. Our review found a positive effect on bone health for supplements; food-based interventions; and educational strategies. Although there may be a publishing bias related to non-significant findings not being published, our results suggest the effectiveness of food based and educational interventions with less economic impact to the individual, as well as less risk of physiological side effects occurring.Entities:
Keywords: aging; bone; vitamin D; calcium
Mesh:
Substances:
Year: 2010 PMID: 22253999 PMCID: PMC3257623 DOI: 10.3390/nu2111086
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Description of methods for systematic search.
Calcium and vitamin D interventions (Food).
| Authors | Date | N | Length | Intervention | Outcome |
|---|---|---|---|---|---|
| Moschonis
| 2010 | 66 | 30 months | Postmenopausal woman from 55–65 years old were randomized to either diet intervention with counseling or control (usual diet and no counseling). The diet group consumed fortified dairy, 3 daily servings of milk and yogurt for 12 months (1200 mg and 7.5 µg vitamin D/day). After 12 months and for additional 18 months, the vitamin D fortified levels increased to 22.5 µg vitamin D/day. | The intervention group had a significant increase in BMD a for arms, total spine, and total body
|
| Manios
| 2007 | 101 | 12 months | Post-menopausal women, ages 55–65, received either calcium and vitamin D fortified dairy (1200 mg calcium/d and 7.5 µg vitamin D3/d, n = 39), calcium supplementation (600 mg to reach 1200 total Ca/day, n = 36)
| The dairy group showed better changes at the hip site, total spine and total BMD, based on DEXA readings Calcium supplementation or control groups did not show changes. |
| The dairy intervention group showed an increase in insulin-like growth factor (IGF)‑I
| |||||
| Bonjour
| 2009 | 37 | 1 month | Elderly women (mean age 84.8 ± 8.1 years) living in long term care facility consumed calcium and vitamin D fortified soft plain cheese (302 mg calcium, 2.5 µg vitamin D, 14.2 g protein). The bone resorption marker carboxy terminal cross‑linked teleopeptide was targeted but other serum markers were measured. | PTH d levels were reduced. Levels of insulin-like growth factor-1, osteocalcin and amino-terminal propeptide of type1 procollagen increased. |
| Hien
| 2009 | 140 | 18 months | Post-menopausal women with low calcium intake; nutrition education to improve calcium intake. Control group stayed with usual diet. Calcium intake, PTH and BMD were measured. | The intervention group showed an increase in calcium intake and a decrease in PTH levels. |
|
[ | |||||
| Solomon
| 2006 | 31,715 | 3 separate mailings | Elderly participants received education materials in the mail geared towards strengthening knowledge of osteoporosis, calcium and vitamin D intake along with other bone healthy behaviors. The controls did not receive the informational packets. | No change or difference in knowledge, perceived susceptibility or diet was reported between the intervention or control. |
| Sedlak
| 2005 | 124 | 6 months | Postmenopausal women were given specific instruction by health care professionals on bone healthy behaviors, including calcium intake. The control group did not receive the focused instruction. | Calcium intake increased in both groups. |
| Wong
| 2004 | 189 | 4 months | All participants had an osteoporotic fracture. The intervention group received three tailored counseling sessions and the control group received standard care. Dietary intake (calcium, protein and calories) were evaluated. | Calcium intake was increased following the intervention. No change in protein or calories. |
|
[ | |||||
| Heaney
| 1999 | 204 | 12 week following 4 week baseline | Men and women, ages 55–85, who commonly consumed below dairy recommendations were given instruction how to meet dairy group recommendation of 3 servings/day. | Following instruction, mean calcium and vitamin D intake improved by 729 mg and 5.8 µg/day, respectively. Other bone nutrients intake (Mg, P, protein) also improved. PTH levels decreased and the bone resorption marker,
|
a Bone mineral density;
b Dual energy X-ray absorptometry;
c Quantitative ultrasound;
d Parathyroid hormone.
Calcium and vitamin D interventions (Supplements).
| Authors | Date | N | Length | Intervention | Outcome |
|---|---|---|---|---|---|
| Seamans
| 2010 | 204 | 22 weeks | Adults (ages ≥64 years) received cholecalciferol supplementation (0, 5, 10, and 15 µg cholecalciferol/d) during winter months on indices of vitamin D status and bone turnover. Mean calcium intake was 874 mg/day. | Increase in serum 25(OH)D a based on supplemental dosage up to 10 µg/day and decrease in parathyroid hormone
|
| Kuwabara
| 2009 | 62 | 30 days | Adults living in long term care facilities received either 200 mg of calcium with or without 800 IU vitamin D. | Serum 25(OH)D levels increased in the supplemented group but the mean level still fell below 20 mg/mL. In those with good compliance, PTH levels were lower in the vitamin D group
|
| Hitz
| 2007 | 11 (hip fractures, control n = 18) | 1 year | Patients with either hip or upper extremity fractures received either 1200 mg calcium and 1400 IU cholecalciferol or placebo (including 200 IU cholecalciferol in multivitamin). Lumbar and pelvis BMD b measured along with biomarkers. | Lumbar BMD was increased in the intervention group. |
| 23 (upper extremity fractures, control n = 27) | PTH was reduced in those with hip fracture and receiving intervention. Effect of intervention was more effective in those <70 years. | ||||
| Prince
| 2006 | 1460 | 5 years | Elderly women were randomized to take a placebo or 600 mg calcium twice per day. BMD and adverse effects were monitored. | Calcium supplemented group did not reduce fracture risk but if focus on those complying (>80% taking the supplement) then those showed improved BMD and bone strength and reduced fracture incidence
|
| Jackson
| 2006 | 36,282 | 7 years | Post-menopausal women (ages 50–79) were assigned to either 1000 mg calcium with 400 IU vitamin D3/day or control group. Fracture rate and bone density were monitored. | Intervention group had slight higher hip BMD. No significant reduction in fracture risk. Kidney stone risk was more elevated in the treatment group. |
| Di Daniele
| 2004 | 120 | 30 months | Peri- and post-menopausal women received calcium and vitamin D supplement. BMD and BMC c were measured. | The placebo group lost a total of BMD
|
| Meier
| 2004 | 55 | 2 year | Healthy adults were given vitamin D3 (500 IU) and calcium (500 mg) after a year of observation during the winter season
| During the intervention, effects of winter on hormones and bone turnover markers were reversed or negated in the supplemented group. |
| Sanders
| 2010 | 2256 | 3–5 years | Older, free living women (≥70 years) in the autumn season were given a single dose of 500,000 IU vitamin D/year to determine if this would reduce risk for falls and fractures. | The intervention group had higher falls and relative risk for falls than the control group. |
| Kärkkäinen
| 2010 | 3139 | 3 years | Ambulatory women were studied. The treatment group received 800 IU vitamin D with 1000 mg calcium/day
| There was no difference in the number of single or multiple falls between groups at the population level. For the subgroup, the supplemented group reduced the number of multiple falls. |
| Kärkkäinen
| 2010 | 593 | 3 years | Ambulatory women were studied. The treatment group received 800 IU vitamin D with 1000 mg calcium/day
| The supplemented group increased total BMD. For those that were deemed compliant (≥80%) in taking supplements, the improvement in BMD (total and femoral) were significant. |
| Pfeifer
| 2009 | 242 | 20 months | Elderly in the community received either 1000 mg calcium or 1000 mg with 800 IU vitamin D. Number of falls and muscle strength were tracked. | Calcium with vitamin D group had reduced quantity of first falls and improvements in muscle strength
|
| Flicker
| 2005 | 625 | 2 years | Seniors living in residential settings with vitamin D levels at least 25 nmol/L were given vitamin D supplements (10,000 weekly dose and then 1,000 IU/day) or assigned a placebo. Calcium (600 mg) was provided to both groups. Falls and fractures were prospectively measured. | The vitamin D supplemented group had a reduced incident rate for falls and fracturing. |
a 25-hydroxyvitamin D;
b Bone mineral density;
c Bone mineral content.
Interventions using bone-healthy nutrients addition to calcium and vitamin D.
| Authors | Date | N | Length | Intervention | Outcome |
|---|---|---|---|---|---|
| Protein | |||||
| Rapuri
| 2003 | 489 | 3 years | Protein as a percentage of calories and effect of calcium intake on bone loss in women (ages 65–77 years) were studied in this cross‑sectional study. BMD was tracked. | Highest protein quartile (mean 78 g) was associated with higher spine, radius and total BMD a for those with higher calcium intakes (over 400 mg)
|
| Sodium | |||||
| Teucher
| 2008 | 11 | 20 weeks (with 5 phases and 4 week washout periods) | Crossover study (5 weeks each phase) with post-menopausal women consumed calcium (low = 518 mg and high = 1284 mg calcium) and salt (3.9 g = low and 11.2 g = high) diets. Calcium absorption and excretion and biomarkers were measured. | Diet high in salt resulted in increased urinary calcium losses and impacted calcium balance on the high calcium diet. Calcium balance on the low calcium was negative for both low and high salt diets. Calcium absorption was more efficient with low calcium but unaffected by salt intake. |
| Soy | |||||
| Alekel
| 2010 | 432 | 36 months | Healthy postmenopausal women with no osteoporosis were given either placebo or calcium and vitamin D with isoflavones (80 or 120 mg). BMD was measured. | BMD declined in all groups. The group with 120 mg of isoflavones was more protective at the femoral neck BMD
|
| Wong
| 2009 | 403 | 24 months | Postmenopausal women were given calcium and vitamin D supplements with additional soy isoflavone (soy hypocotyl aglycone) of either 80 mg or 120 mg soy isoflavone. BMD and BMC b changes were tracked. | Participants in the 120 mg soy isoflavone group had smaller loss in total BMD than the placebo. |
| Cheong
| 2007 | 13 | 50 day intervention per phase | Postmenopausal women consumed 43 g soy protein via baked goods and beverages. Each intervention contained soy protein with either 0, 97.5, or 135.5 mg total isoflavones. Order of dosage was randomized. | No change in bone resorption markers (urinary cross-linked N teleopeptides of type I collagen and serum osteocalcin) related to change in dosage. |
| (3 way crossover) | |||||
| Vitamin K | |||||
| Booth
| 2008 | 452 | 3 years | Men and women (ages 60–80) received either a multivitamin with either 500 µg/d or no phylloquinone. Both groups received calcium (600 mg elemental calcium/day) and vitamin D (400 IU/day) in a separate supplement. Femoral neck, lumbar and total BMD were measured. | No difference in BMD. Percent of undercarboxylated osteocalcin was lower in the supplemented group, indicating improved vitamin K status. |
| Bolton-Smith
| 2007 | 244 | 2 years | Women (ages ≤60 years) with no osteoporosis were treated with either placebo, 200 µg vitamin K, 400 IU vitamin D and 1000 mg calcium, or vitamin K with vitamin D and calcium. DEXA c measured wrist and hip bone mineral content. | Women taking the combination of vitamin K, vitamin D and calcium showed an increase in BMC and BMD at the distal radius
|
| Braam
| 2003 | 181 | 3 years | Post-menopausal women (ages 50–60) were assigned either a combination of calcium/magnesium/zinc/vitamin D with vitamin K (1 mg vitamin K/day) or combination without vitamin K or placebo. BMD of femoral neck and lumbar area were targeted. | The vitamin K supplemented group had less femoral neck bone loss. |
a Bone mineral density;
b Bone mineral content;
c Dual energy X-ray absorptometry;
d 25-hydroxyvitamin D.
Portfolio diets on bone health.
| Authors | Date | N | Length | Intervention | Outcome |
|---|---|---|---|---|---|
| Dash Diet | |||||
| Lin
| 2007 | 810 | 18 months | Men and women (mean age: 50 ± 8.9 years) either followed established guidelines or the DASH diet. Nutrient intakes including calcium, potassium and magnesium were evaluated. | Those following the DASH increased calcium, potassium and magnesium intake
|
| Mediterranean Diet | |||||
| Bulló | 2009 | 238 | 12 months | Elderly men and women (ages 60–80 years) were randomized to either control (low fat diet), Mediterranean diet with olive oil supplement or Mediterranean diet with mixed nuts. Changes in bone biomarkers were evaluated. Bone mass was measured by QUS a. | The group consuming mixed nuts had a high acid load. This group had higher PTH b levels
|
a Quantitative ultrasound;
b Parathyroid hormone.